Skip to main content
NCBI home page
Applied Microbiology logoLink to Applied Microbiology
. 1973 Sep;26(3):264–267. doi: 10.1128/am.26.3.264-267.1973

Suppression of Herpes Simplex Virus Infection by Phosphonoacetic Acid

N L Shipkowitz 1, R R Bower 1, R N Appell 1, C W Nordeen 1, L R Overby 1, W R Roderick 1, J B Schleicher 1, A M Von Esch 1
PMCID: PMC379771  PMID: 4356456

Abstract

Disodium phosphonoacetate when administered orally or topically to mice experimentally infected with herpes simplex virus was able to significantly reduce the mortality associated with the agent. In addition, this compound was able to reduce herpesvirus lesions on the corneas of infected rabbits.

Full text

PDF
264

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam E., Kaufman R. H., Melnick J. L., Levy A. H., Rawls W. E. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. 3. Houston, Texas. Am J Epidemiol. 1972 Dec;96(6):427–442. doi: 10.1093/oxfordjournals.aje.a121475. [DOI] [PubMed] [Google Scholar]
  2. Allen J. H. Common external ocular infections. Postgrad Med. 1969 May;45(5):144–148. doi: 10.1080/00325481.1969.11697135. [DOI] [PubMed] [Google Scholar]
  3. Aurelian L. Possible role of Herpesvirus hominis, type 2, in human cervical cancer. Fed Proc. 1972 Nov-Dec;31(6):1651–1659. [PubMed] [Google Scholar]
  4. Aurelian L., Royston I., Davis H. J. Antibody to genital herpes simplex virus: association with cervical atypia and carcinoma in situ. J Natl Cancer Inst. 1970 Sep;45(3):455–464. [PubMed] [Google Scholar]
  5. Chow A. W., Roland A., Fiala M., Hryniuk W., Weil M. L., Geme J. S., Jr, Guze L. B. Cytosine arabinoside therapy for herpes simplex encephalitis--clinical experience with six patients. Antimicrob Agents Chemother. 1973 Mar;3(3):412–417. doi: 10.1128/aac.3.3.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Douglas R. G., Jr, Anderson S., Weg J. G., Williams T., Jenkins D. E., Knight V., Beall A. C., Jr Herpes simplex virus pneumonia. Occurrence in an allotransplanted lung. JAMA. 1969 Nov 3;210(5):902–904. [PubMed] [Google Scholar]
  7. Feorino P., Palmer E. L., Martin M. L. Incidence of herpesvirus antibody among leukemic and nasopharyngeal carcinoma patients. Proc Soc Exp Biol Med. 1972 Mar;139(3):913–915. doi: 10.3181/00379727-139-36265. [DOI] [PubMed] [Google Scholar]
  8. Granoff A. Herpesvirus and the frog renal adenocarcinoma. Fed Proc. 1972 Nov-Dec;31(6):1626–1633. [PubMed] [Google Scholar]
  9. Henle W., Henle G., Ho H. C., Burtin P., Cachin Y., Clifford P., de Schryver A., de-Thé G., Diehl V., Klein G. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst. 1970 Jan;44(1):225–231. [PubMed] [Google Scholar]
  10. Hilleman M. R. Marek's disease vaccine: its implications in biology and medicine. Avian Dis. 1972 Apr;16(1):191–199. [PubMed] [Google Scholar]
  11. Hinze H. C., Chipman P. J. Role of herpesviruses in malignant lymphoma in rabbits. Fed Proc. 1972 Nov-Dec;31(6):1639–1642. [PubMed] [Google Scholar]
  12. Hunt R. D., Meléndez L. V., King N. W., Garcia F. G. Herpesvirus saimiri malignant lymphoma in spider monkeys. A new susceptible host. J Med Primatol. 1972;1(2):114–128. doi: 10.1159/000460372. [DOI] [PubMed] [Google Scholar]
  13. Inglot A. D., Kochman M., Mastalerz P. Activity of salicylates as inhibitors of virus replication in vitro and their mode of action. Acta Virol. 1966 May;10(3):185–194. [PubMed] [Google Scholar]
  14. Inglot A. D., Kochman M., Mastalerz P. Antiviral activity of p-nitrobenzylphosphonic acid. Nature. 1965 Aug 14;207(998):784–785. doi: 10.1038/207784a0. [DOI] [PubMed] [Google Scholar]
  15. Inglot A. D., Kochman M., Mastalerz P., Pelczarska A. Peculiarities of the antiviral action of dibenzylphosphinic acid. Acta Virol. 1967 May;11(3):199–205. [PubMed] [Google Scholar]
  16. Kochman M., Mastalerz P., Inglot A. D. Inhibition of encephalomyocarditis virus replication by simple phosphonic and carboxylic acids. Nature. 1965 Aug 21;207(999):888–890. doi: 10.1038/207888a0. [DOI] [PubMed] [Google Scholar]
  17. Melnick J. L., Rawls W. E. Herpesvirus type 2 and cervical carcinoma. Ann N Y Acad Sci. 1970 Oct 30;174(2):993–998. doi: 10.1111/j.1749-6632.1970.tb45620.x. [DOI] [PubMed] [Google Scholar]
  18. Melèndez L. V., Hunt R. D., Daniel M. D., Fraser C. E., Barahona H. H., King N. W., Garcìa F. G. Herpesviruses saimiri and ateles--their role in malignant lymphomas of monkeys. Fed Proc. 1972 Nov-Dec;31(6):1643–1650. [PubMed] [Google Scholar]
  19. Nahmias A. J., Josey W. E., Naib Z. M., Luce C. F., Guest B. A. Antibodies to Herpesvirus hominis types 1 and 2 in humans. II. Women with cervical cancer. Am J Epidemiol. 1970 Jun;91(6):547–552. doi: 10.1093/oxfordjournals.aje.a121166. [DOI] [PubMed] [Google Scholar]
  20. Purchase H. G. Role of herpesviruses in Marek's disease, a malignant lymphoma of chickens. Fed Proc. 1972 Nov-Dec;31(6):1634–1638. [PubMed] [Google Scholar]
  21. Rawls W. E., Tompkins W. A., Melnick J. L. The association of herpesvirus type 2 and carcinoma of the uterine cervix. Am J Epidemiol. 1969 May;89(5):547–554. doi: 10.1093/oxfordjournals.aje.a120967. [DOI] [PubMed] [Google Scholar]
  22. SYDISKIS R. J., SCHULTZ I. HERPES SIMPLEX SKIN INFECTION IN MICE. J Infect Dis. 1965 Jun;115:237–246. doi: 10.1093/infdis/115.3.237. [DOI] [PubMed] [Google Scholar]
  23. Sprecher-Goldberger S., Thiry L., Gould I., Fassin Y., Gompel C. Increasing antibody titers to herpes simplex virus type 2 during follow-up of women with cervical dysplasia. Am J Epidemiol. 1973 Feb;97(2):103–110. doi: 10.1093/oxfordjournals.aje.a121486. [DOI] [PubMed] [Google Scholar]
  24. Tomlinson A. H., Maccallum F. O. The effect of 5-iodo-2'-deoxyuridine on herpes simplex virus infections in guinea-pig skin. Br J Exp Pathol. 1968 Jun;49(3):277–282. [PMC free article] [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES